Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization

Some studies have shown that sorafenib could significantly prolong the overall survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization (TACE). However, other studies revealed that patients had no access to sorafenib-related survival benef...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Kun He, Zelong Yang, Xinyu Liu, Yanling Yang, Wenjie Song, Shangyu Wang, Yong Chen
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2022-12-01
Cyfres:	Current Oncology
Pynciau:	predictors hepatocellular carcinoma vascular endothelial growth factor transcatheter arterial chemoembolization sorafenib
Mynediad Ar-lein:	https://www.mdpi.com/1718-7729/30/1/38
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!